Which platelet function studies are indicated for a patient with easy bruising?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Platelet Studies for Easy Bruising

For a patient with easy bruising and suspected platelet dysfunction, begin with first-step tests including blood smear, light transmission aggregometry (LTA) with 5 agonists (epinephrine, ADP, collagen, arachidonic acid, ristocetin), granule release assays (ATP/ADP secretion), and flow cytometry for major platelet glycoproteins (GPIIb/IIIa, GPIb, GPIb/IX). 1

Initial Clinical Assessment

Before ordering platelet studies, evaluate:

  • Bleeding history specifics: unexplained/extensive bruising, epistaxis, menorrhagia, bleeding with dental extractions or surgery
  • Use a bleeding assessment tool (BAT) to quantify symptom severity and identify who needs testing 1
  • Medication review: drugs interfering with platelet function
  • Family history: inherited bleeding disorders, myelodysplasia, acute myeloid leukemia
  • Physical exam findings: syndromic features (hearing loss, cardiac/facial dysmorphisms, skin discoloration, mental retardation) 1

Preliminary Laboratory Work

Before platelet function testing, obtain:

  • Complete blood count with platelet count
  • Prothrombin time (PT)
  • Activated partial thromboplastin time (aPTT)
  • von Willebrand factor screening (VWF antigen, ristocetin cofactor activity, factor VIII) 1

Proceed to platelet function studies only if these are normal. Note that mild thrombocytopenia should not exclude platelet function testing, as several inherited platelet function disorders (IPFD) present with low platelet counts. 1

First-Step Platelet Studies (Diagnostic Yield: ~40%)

These tests require approximately 21-28 mL of blood and can diagnose up to 40% of all inherited platelet function disorders: 1

1. Blood Smear Examination

Look for altered platelet size/structure or abnormalities in other cells (stomatocytosis, neutrophil inclusion bodies) that suggest specific disorders 1

2. Light Transmission Aggregometry (LTA)

Test with 5 agonists: 1

  • Epinephrine (note: isolated defects are common in healthy individuals; only pursue if other abnormalities present)
  • ADP
  • Collagen
  • Arachidonic acid
  • Ristocetin

3. Granule Release Assessment

  • ATP/ADP secretion via lumiaggregometry (preferred), luminometry, or HPLC
  • α-granule markers measured by ELISA or flow cytometry (P-selectin/CD62P on activated platelets) 1

4. Flow Cytometry for Glycoproteins

On resting platelets, test antibodies against: 1

  • GPIIb/IIIa (CD41)
  • GPIIIa (CD61)
  • GPIb (CD42b)
  • GPIb/IX (CD42a)

On activated platelets:

  • GPIIb/IIIa activation epitope (PAC-1)

Reduced glycoprotein expression suggests Glanzmann thrombasthenia, Bernard-Soulier syndrome, or other well-defined disorders.

Critical Pitfall

Do NOT use PFA-100 or skin bleeding time as screening tests—they have insufficient specificity and sensitivity for diagnosing inherited platelet function disorders. 1

Second-Step Studies (If First-Step Normal but Suspicion Remains)

These require 3-15 mL blood and detect an additional 7% of disorders, with diagnostic suspicion raised for another 40%: 1

Expanded LTA Panel

Test responses to: α-thrombin, TRAP-6, U46619, CRP, convulxin, PAR-4 activating peptide, PMA, A23187 1

Additional Flow Cytometry

  • GPIa/IIa (CD31, CD49b)
  • GPIV (CD36)
  • GPVI
  • Annexin V binding (for procoagulant activity defects—Scott syndrome, Stormorken syndrome) 1

Other Second-Step Tests

  • Clot retraction: incubate non-anticoagulated whole blood 60 min at 37°C in glass tubes
  • Serum thromboxane B2 (TxB2): ELISA or RIA to detect arachidonic acid metabolism defects
  • Transmission electron microscopy: count α- and dense-granules, identify structural alterations 1

Ristocetin Mixing Studies

If enhanced ristocetin-induced aggregation detected, perform mixing tests to distinguish VWD type 2B (plasma origin) from platelet-type VWD (platelet origin) 1

Third-Step Studies (Specialized Centers Only)

For undiagnosed cases with strong clinical suspicion:

  • Biochemical studies
  • Receptor binding assays
  • Molecular genetic testing 1

Important Caveats

Anticoagulant choice matters: Citrate is preferred for flow cytometric platelet tests, though expert consensus on alternatives (particularly heparin) remains uncertain 2

Timing: Repeated platelet studies should be separated by at least 1 month to allow disappearance of acquired interfering factors 1

Complex inheritance: Mild bleeding can result from co-inheritance of multiple heterozygous platelet gene defects or combination with other hemostatic defects (e.g., type 1 VWD) 1

Genetic testing limitations: While first-line exome analysis is conceivable, proving causation of specific sequence variations requires phenotypic information except for well-defined forms 1

References

Related Questions

What is the appropriate evaluation and management for mild bilateral lower extremity bruising?
How should I evaluate and manage a 44-year-old woman presenting with frequent bruising?
Patient with easy bruising and a family history of leukemia, what tests should be ordered?
How should I investigate a patient with multiple bruises localized to a single thigh?
What screening tests are indicated for a 64‑year‑old woman with easy bruising and a son who has thrombocytopenia and chronic immune deficiency?
What is the appropriate evaluation and management for an adult male presenting with diarrhea and a penile rash?
Is it appropriate to administer cisplatin at a dose of 40 mg per square meter to the patient?
Can you provide a step-by-step guide for interpreting ferritin levels?
What is the most likely cause of a maculopapular rash that appears after a resolved fever in a patient without respiratory symptoms?
What are the appropriate dosages of ofloxacin and Augmentin (amoxicillin/clavulanate) for treating an ear infection with a perforated tympanic membrane?
Is it safe for a 69-year-old female with a history of pulmonary embolism and deep‑vein thrombosis who is taking rivaroxaban (Xarelto) and now has a subconjunctival hemorrhage to continue the anticoagulant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.